Advanced & Comprehensive Health Panels - [SAVE 20%]

Save 20% on Advanced & Comprehensive Health & Wellness Lab Tests Panels. - Anti-Aging, Anemia Health , Baseline Biomarkers , Cancer Tumor Markers , Chronic Fatigue Syndrome , Diabetes Management , Digestive Health , Fitness , Heart Health , Hormone Health, Men , Hormone Health, Women , Inflammatory Bowel Disease , Internist Panel , Kidney Health , Liver Health , Menopause , Performance , Reproductive Hormones , Thyroid Health , Vitamins & Minerals , Weight Management .

  • Promotion Code:
  • ULTAADV














The Digestive Health - Advanced contains the following tests

  • C-Reactive Protein (CRP) 
  • CBC (includes Differential and Platelets) 
  • Comprehensive Metabolic Panel (CMP)
  • Fecal Globin by Immunochemistry (InSure®) 
  • Ferritin
  • Folate, Serum
  • Iron and Total Iron Binding Capacity (TIBC)
  • QuestAssureD™ 25-Hydroxyvitamin D (D2, D3), LC/MS/MS 
  • Transferrin
  • Vitamin B12 (Cobalamin) 
  • Celiac Disease Comprehensive Panel (w/ Reflexes)

Specimens from children less than 4 years of age (i.e., less than 48 months) are not appropriate for this test. The test for children 4 years of age and younger is the Celiac Disease Comprehensive Panel, Infant (test code 15981).

Includes

Tissue Transglutaminase, IgA with Reflexes; Total IgA with Reflex

IMPORTANT - Note this is Reflex Test which if additional tests are run you will be charged for the specific tests that the lab peforms. Additional test will be run if the following criteria are met.


If the Tissue Transglutaminase IgA is positive, 

1. Endomysial Antibody Screen (IgA) will be performed at an additional charge (CPT code(s): 86255).

If the Endomysial Antibody Screen (IgA) is positive, 

2. Endomysial Antibody Titer will be performed at an additional charge (CPT code(s): 86256).

If the Total IgA is less than the lower limit of the reference range, based on age

3. Tissue Transglutaminase IgG will be performed at an additional charge (CPT code(s): 83516).

Clinical Significance

Celiac disease is caused by an immune response to gluten in genetically sensitive individuals. The diagnosis is largely based on a biopsy of the small intestine, but serologic tests also help support a diagnosis and may assist identification of patients who may require biopsy.

Tissue transglutaminase antibodies (tTG, IgA) is a marker with 95% sensitivity and specificity. Total IgA is measured because 2-3% of celiac disease patients are IgA deficient. Because tTG, IgA, and anti-Gliadin IgA tend to decrease in patients on a gluten-free diet, these markers are also used to assess dietary compliance.

The endomysial antibody (EMA, IgA) assay has high specificity for celiac disease and is used to confirm positive anti-tTG results.


Digestive Health - Comprehensive contains the following tests: 

  • C-Reactive Protein (CRP) 
  • CBC (includes Differential and Platelets) 
  • Comprehensive Metabolic Panel (CMP)
  • Fecal Globin by Immunochemistry (InSure®) 
  • Ferritin
  • Folate, Serum
  • Gliadin (Deamidated Peptide) Antibody (IgA) 
  • Gliadin (Deamidated Peptide) Antibody (IgG) 
  • Iron and Total Iron Binding Capacity (TIBC)
  • Lipid Panel with Ratios
  • Magnesium
  • Prealbumin 
  • QuestAssureD™ 25-Hydroxyvitamin D (D2, D3), LC/MS/MS 
  • Transferrin
  • TSH
  • Vitamin A (Retinol)
  • Vitamin B12 (Cobalamin) 
  • Vitamin K
  • Celiac Disease Comprehensive Panel (w/ Reflexes)

Specimens from children less than 4 years of age (i.e., less than 48 months) are not appropriate for this test. The test for children 4 years of age and younger is the Celiac Disease Comprehensive Panel, Infant (test code 15981).

Includes

Tissue Transglutaminase, IgA with Reflexes; Total IgA with Reflex

IMPORTANT - Note this is Reflex Test which if additional tests are run you will be charged for the specific tests that the lab peforms. Additional test will be run if the following criteria are met.


If the Tissue Transglutaminase IgA is positive, 

1. Endomysial Antibody Screen (IgA) will be performed at an additional charge (CPT code(s): 86255).

If the Endomysial Antibody Screen (IgA) is positive, 

2. Endomysial Antibody Titer will be performed at an additional charge (CPT code(s): 86256).

If the Total IgA is less than the lower limit of the reference range, based on age, 

3. Tissue Transglutaminase IgG will be performed at an additional charge (CPT code(s): 83516).

Clinical Significance

Celiac disease is caused by an immune response to gluten in genetically sensitive individuals. The diagnosis is largely based on a biopsy of the small intestine, but serologic tests also help support a diagnosis and may assist identification of patients who may require biopsy.

Tissue transglutaminase antibodies (tTG, IgA) is a marker with 95% sensitivity and specificity. Total IgA is measured because 2-3% of celiac disease patients are IgA deficient. Because tTG, IgA, and anti-Gliadin IgA tend to decrease in patients on a gluten-free diet, these markers are also used to assess dietary compliance.

The endomysial antibody (EMA, IgA) assay has high specificity for celiac disease and is used to confirm positive anti-tTG results.


For the most comprehensive look at your biomarkers for Epstein-Barr (EBV), we recommend the Epstein-Barr (EBV) Comprehensive Panel, as only one may come out positive:

  • EBV-VCA IgG/IgM (viral capsid antigen): A positive IgG means you’ve had or currently have the infection; A positive IgM means the virus has been reactivated.
  • EBV-EBNA IgG (nuclear antigen): A positive test result is usually associated with past infections.
  • EBV-EA-D IgG (early antigen): A positive EA IgG may mean you have an active or reactivated infection.
  • The Epstein-Barr EBV Early Antigen D Ab IgG test that will let one know if the virus is actively replicating.

Epstein-Barr (EBV) is a virus that causes mononucleosis, also known as the kissing disease, is a viral infection that is thought to be transmitted through the saliva of those who are infected. The Epstein-Barr virus creates an inactive infection in the body where it lies dormant. It can awaken and reactivate itself, even many years after its initial activation.

The reactivated virus has the potential to induce many debilitating autoimmune symptoms. In some, the infection may not be adequately suppressed and may cause or exacerbate autoimmune diseases. 

The Epstein-Barr (EBV) tests are used to figure out if a person has a reactivated infection. 

Reference Range(s)

Epstein-Barr Virus VCA Antibody (IgM)

U/mLInterpretation

  • <36.00 Negative
  • 36.00-43.99 Equivocal
  • >43.99 Positive

Epstein-Barr Virus VCA Antibody (IgG)

U/mLInterpretation

  • <18.00 Negative
  • 18.00-21.99 Equivocal
  • >21.99 Positive


Epstein-Barr Virus Nuclear Antigen (EBNA) Antibody (IgG)

U/mLInterpretation

  • <18.00 Negative
  • 18.00-21.99 Equivocal
  • >21.99 Positive

Epstein-Barr Virus Early Antigen D Antibody (IgG)

U/mLInterpretation

  • <9.00 Negative
  • 9.00-10.99 Equivocal
  • >10.99 Positive

Most Popular






IMPORTANT - Note the Estradiol test included in this panel is not for children that have yet to start their menstrual cycle.  If this test is ordered for a child that has yet to begin their menstrual cycle Quest Diagnostics labs will substitute Estradiol, Free, LC/MS/MS at an additional fee of $290.00

 


IMPORTANT - Note the Estradiol test included in this panel is not for children that have yet to start their menstrual cycle.  If this test is ordered for a child that has yet to begin their menstrual cycle Quest Diagnostics labs will substitute Estradiol, Free, LC/MS/MS at an additional fee of $290.00






Keto Lab Test Panel - Comprehensive includes the following tests.

  • Apolipoprotein B, Cardio IQ™ 
  • C-Peptide
  • CBC (includes Differential and Platelets) 
  • Comprehensive Metabolic Panel (CMP)
  • Ferritin
  • Hemoglobin A1c (HgbA1C)
  • hs-CRP
  • Insulin
  • Lipid Panel, Cardio IQ™ 
  • Lipoprotein (a), Cardio IQ™ 
  • Lipoprotein Fractionation, Ion Mobility, Cardio IQ™ 
  • Magnesium
  • QuestAssureD™ 25-Hydroxyvitamin D (D2, D3), LC/MS/MS 
  • T3, Free
  • T4 (Thyroxine), Total
  • TSH
  • Uric Acid
  • Urinalysis (UA), Complete
  • Vitamin B12 (Cobalamin)





Most Popular






Most Popular

The STD - Comprehensive Panel contains the following tests:

  • Chlamydia/Neisseria gonorrhoeae RNA, TMA
  • RPR (Monitor) with Reflex to Titer
  • Herpes Simplex Virus 1/2 (IgG), Type-Specific Antibodies (HerpeSelect®)
  • Hepatitis Panel, General

Due to the consultation and reporting requirements, we are unable to offer HIV testing at this time.

Chlamydia/Neisseria gonorrhoeae RNA, TMA

Patient Preparation 

Urine specimen: The patient should not have urinated for at least one hour prior to specimen collection. Female patients should not cleanse the labial area prior to providing the specimen.

Urine: Patient should not have urinated within one hour prior to collection. Female patients should not cleanse the labial area prior to providing the specimen. Direct patient to provide a first-catch urine (a maximum of 20-30 mL of the initial urine stream) into a urine collection cup free of any preservatives. 2 mL of urine specimen must be transferred into the APTIMA® specimen transport within 24 hours of collection and before being assayed. Use tube provided in the urine specimen collection kit for urine specimens. The fluid (urine plus transport media) level in the urine tube must fall within the clear pane on the tube label.

 

Clinical Significance

C. trachomatis infections are the leading cause of sexually transmitted diseases in the United States. C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis. It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of Chlamydialinfections are severe if left untreated. Approximately half of Chlamydial infections are asymptomatic.
Neisseria gonorrhoeae (gonococci) is the causative agent of gonorrhea. In men, this disease generally results in anterior urethritis accompanied by purulent exudate. In women, the disease is most often found in the cervix, but the vagina and uterus may also be infected.

Herpes Simplex Virus 1/2 (IgG), Type-Specific Antibodies (HerpeSelect®) 

HSV 1 IGG, TYPE SPECIFIC AB

HSV 2 IGG, TYPE SPECIFIC AB

Diagnose HSV infection when lesions are absent; determine HSV type

Reference Range(s)

Index Interpretation

<0.90 Negative

0.90-1.09 Equivocal

>1.09 Positive

This assay utilizes recombinant type-specific antigens to differentiate HSV-1 from HSV-2 infections. A index positive result cannot distinguish between recent and past infection. If recent HSV infection is suspected but the results are negative or equivocal, the assay should be repeated in 4-6 weeks. The performance index characteristics of the assay have not been established for pediatric populations, immunocompromised patients, or neonatal screening.

Limitations

Individuals infected with HSV may not exhibit detectable IgG antibody in the early stages of infection.

Clinical Significance

Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV Type 2 is more commonly associated with genital tract and neonatal infections, while HSV Type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients.

 

Syphilis RPR ( RPR (Monitor) with Reflex to Titer)

Reference Range(s)

Non-Reactive

Clinical Significance

This is a non-treponemal screening test for syphilis. False positive results may occur due to systemic lupus erythematosus, leprosy, brucellosis, atypical pneumonia, typhus, yaws, pinta, or pregnancy. Monitoring of RPR is helpful in assessing effectiveness of therapy.

IMPORTANT

A positive RPR screen must be followed by a specific treponemal antibody test (e.g., FTA-ABS):

A positive result on the second method confirms the screening result and the affected person is diagnosed with syphilis.

A negative result on the treponemal test may mean that the initial RPR test was falsely positive. Further testing and investigation may be done to determine the cause of the false positive.

Limitations

False-positive results have been associated in patients with infections, pregnancy, autoimmune disease, old age, Gaucher disease, and malignancy.

Hepatitis Panel, General

Hepatitis A Antibody, Total; Hepatitis B Surface Antibody, Qualitative; Hepatitis B Surface Antigen with Reflex Confirmation; Hepatitis B Core Antibody, Total; Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR

Hepatitis B Surface Antigen with Reflex Confirmation: Positive samples will be confirmed based on the manufacturer's FDA approved recommendations at an additional charge (CPT code(s): 87341).


If Hepatitis C Antibody is reactive, Hepatitis C Viral RNA, Quantitative, Real-Time PCR will be performed at an additional charge (CPT code(s): 87522).